1179756

Partner Therapeutics, Inc. — FEI 3017531261

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 16, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, MA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
909521 CFR 600.80(c)(1)(i)Reporting Requirements - 15-day alert
909621 CFR 600.80(c)(1)(ii)Reporting Requirements - 15-day alert follow up